XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Condensed Statements Of Cash Flows
$ in Thousands, SFr in Millions
 3 Months Ended 12 Months Ended
Oct. 31, 2022
USD ($)
Oct. 31, 2021
USD ($)
Jul. 31, 2022
USD ($)
Jul. 31, 2021
USD ($)
Cash flows from operating activities:        
Net loss $ (143,560) $ (142,521)    
Adjustments to reconcile net loss to net cash provided by operating activities:        
Depreciation and amortization 64,614 61,489    
Stock-based compensation expense 6,345 6,425    
Deferred income taxes, net (58,006) (56,603)    
Other non-cash expense (income), net   (2,825)    
Other Noncash Expense 8,615      
Changes in assets and liabilities:        
Trade receivables, net 264,285 236,748    
Inventories, net (31,924) (23,105)    
Accounts payable and accrued liabilities 2,508 12,164    
Deferred revenue 279,221 286,369    
Income taxes payable - other (20,460) (2,198)    
Other assets and liabilities, net (38,647) (26,922)    
Net cash provided by operating activities 332,991 349,021    
Cash flows from investing activities:        
Capital expenditures (124,099) (50,130)    
Return of deposit for acquisition of business 114,506 0 $ (114,400)  
Acquisition of business, net of cash acquired (38,567) 0    
Investments in short-term deposits (86,756) 0    
Other investing activities, net 385 10,273    
Net cash used in investing activities (134,531) (39,857)    
Cash flows from financing activities:        
Repayments of borrowings under Vail Holdings Credit Agreement (15,625) (15,625)    
Repayments of borrowings under Whistler Credit Agreement 0 (23,145)    
Employee taxes paid for share award exercises (4,043) (10,517)    
Dividends paid (77,018) (35,594)    
Other financing activities, net (7,942) 147    
Net cash used in financing activities (104,628) (84,734)    
Effect of exchange rate changes on cash, cash equivalents and restricted cash (18,876) (142)    
Net increase in cash, cash equivalents and restricted cash 74,956 224,288    
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1,201,063 1,482,862 $ 1,126,107 $ 1,258,574
Accrued capital expenditures $ 21,069 $ 8,582